<DOC>
	<DOCNO>NCT00014378</DOCNO>
	<brief_summary>RATIONALE : The Chinese herb Huang Lian contain ingredient may slow growth cancer cell may effective treatment solid tumor . PURPOSE : Phase I trial study effectiveness Huang Lian treat patient advance solid tumor .</brief_summary>
	<brief_title>Huang Lian ( Chinese Herb ) Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose Huang Lian ( Chinese herb ) patient advance solid tumor . - Determine optimal pharmacologic , molecular , biologic parameter treatment regimen patient . - Assess preliminary therapeutic activity treatment regimen patient population . OUTLINE : This dose-escalation study . Patients receive oral Huang Lian ( Chinese herb ) 4 time daily . Treatment repeat every 21 day absence disease progression unacceptable toxicity . Cohorts 1-6 patient receive escalate dos Huang Lian maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 2 6 patient experience dose-liming toxicity . PROJECTED ACCRUAL : Approximately 20-30 patient accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced solid tumor refractory standard therapy standard therapy exist Measurable evaluable disease No CNS primary tumor metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : WBC great 3,500/mm^3 Neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 mg/dL AST ALT great 2.5 time upper limit normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : No history cardiac arrhythmia ( include atrial fibrillation ) No congestive heart failure No angina myocardial infarction within past 6 month QTc interval great 0.48 sec Other : Potassium least 3.5 mEq/L Magnesium least 1.4 mEq/L No mental incapacity would preclude informed consent No serious uncontrolled infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 2 month study participation PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : At least 4 week since prior chemotherapy recover Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Not specify Other : At least 2 week since prior herbal therapy cancer recover No concurrent class IA III antiarrhythmic agent ( e.g. , quinidine , procainamide , disopyramide , sotalol , amiodarone , ibutilide , almokalant , dofetilide ) No concurrent tricyclic antidepressant ( e.g. , amitriptyline , doxepin , desipramine , imipramine , clomipramine ) No concurrent antiseizure medication ( include dilantin phenobarbital ) underlie seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>